
Ongoing Mutations in Polytreated Metastatic Cancer Patients May Create a New Chance of Treatment with Unexpected Drugs
Author(s) -
Mahmoud Mahmoud Abbass Ellithy,
Amr S Saad,
Mahmoud Salah Abdelsalam,
Amr Elsebaei
Publication year - 2018
Publication title -
journal of cancer therapy
Language(s) - English
Resource type - Journals
eISSN - 2151-1942
pISSN - 2151-1934
DOI - 10.4236/jct.2018.911069
Subject(s) - medicine , irinotecan , pemetrexed , temozolomide , gemcitabine , dacarbazine , oncology , kras , cancer , colorectal cancer , breast cancer , erlotinib , chemotherapy , cisplatin , epidermal growth factor receptor